Biovest in the News

February 2012
Gulf Coast Business Review
Double Down - Promise of Personalized Lymphoma Vaccine

January 2012
HemOnc Today
Follicular Lymphoma Vaccine Specifically Targets Tumor Cells

OneMedPlace Research
OneMedPlace Initiates Research Coverage on BVTI & BiovaxID Cancer Vaccine

December 2011
Fox News
5 Medical Advances Predicted for 2012 (Medicine Gets Closer to Treating Cancer with Vaccines)

Yale Journal of Biology & Medicine
Cancer Immunotherapy Takes a Multi-Faceted Approach to Kick the Immune System into Gear

Genetic Engineering & Biotechnology News
Vaccine Isotype Seems to Affect Clinical Outcome in BiovaxID Trials

Newsweek Magazine
Could This Be the End of Cancer?

November 2011
Journal of Clinical Oncology
Idiotype Vaccination as Consolidation Therapy:
Time for Integration into Standard-of-Care for Follicular Lymphoma?

Genetic Engineering & Biotechnology News
Does Clinical Success Mean Commercial Success for Cancer Vaccines?

October 2011
Minneapolis Star Tribune
Biovest's Cancer Vaccine Gets Personal

September 2011
HemOnc Today
Cancer Vaccines Targeted by Many as the "Holy Grail" for Tumors

June 2011
Cancer Research Institute-MD Becker ASCO Cancer Immunotherapy Report
Interview with MD Anderson's Dr. Larry Kwak on BiovaxID

Reason Magazine
Winning the War on Cancer

Genetic Engineering & Biotechnology News
Naval Health Research Center Reports Novel Use for Biovest HF Technology

Wall Street Journal
Enlisting the Body to Fight Cancer

February 2011
Minnesota Finance & Commerce
Biovest Has Big Plans in Coon Rapids

Star Tribune
Minnesota Gov Hosts Press Event for Biovest's Manufacturing Plans

November 2010
Barron's
The Next Cancer-Immunotherapy Star

October 2010
Genetic Engineering News
What Comes After Dendreon’s Provenge?

June 2010
Scientific American
Vaccines Derived from Patients' Tumor Cells Are Individualizing Cancer Treatment

April 2010
MD Anderson Cancer Center Newsroom
Larry Kwak, M.D., Ph.D. Named to TIME Magazine's 100 Most Influential People in the World

Cure Magazine
Getting Personal

The Pharma Letter
Biovest Cancer Vaccine Touted as Next Success

September 2009
Time Magazine
America's Health Checkup

June 2009
National Cancer Institute (NCI) Cancer Bulletin
Treatment Vaccines for Cancer Perform Well in Clinical Trials

May 2009
NBC Nightly News with Brian Williams (Video):
Cancer Vaccines Offer New Hope

Bloomberg News:
Immune-Boosting Vaccines Show Promise in Two Cancer Types

USA Today:
Experimental vaccine delays relapse in some cancer patients

The links to third party media websites are provided solely as a courtesy.  Neither Biovest International, Inc., nor any of its affiliates, endorse, confirm or adopt the information provided by any third party website or accept any responsibility for accuracy which is the sole responsibility of each respective publication and/or website provider.  Biovest undertakes no obligation to revise or update the contents of any third party website to reflect events or circumstances after its issuance or otherwise.  The reader should review all disclaimers contained in any third party website.  Biovest is subject to significant risks, and a discussion of such risks can be found by reviewing Biovest’s SEC filings including Annual and Quarterly Reports as filed on Form 10-K and Form 10-Q respectively.